These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38290253)

  • 1. A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies.
    Adhikari S; Nath P; Das A; Datta A; Baildya N; Duttaroy AK; Pathak S
    Biomed Pharmacother; 2024 Feb; 171():116211. PubMed ID: 38290253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.
    Leon IE; Cadavid-Vargas JF; Di Virgilio AL; Etcheverry SB
    Curr Med Chem; 2017; 24(2):112-148. PubMed ID: 27554807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer metallodrugs: where is the next cisplatin?
    Hanif M; Hartinger CG
    Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V; Nováková O
    Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation anticancer metallodrugs.
    Komeda S; Casini A
    Curr Top Med Chem; 2012; 12(3):219-35. PubMed ID: 22236158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoroorganic Metal Complexes in Therapeutics.
    Demkowicz S; Kozak W; Daśko M; Rachon J
    Mini Rev Med Chem; 2016; 16(17):1359-1373. PubMed ID: 27145849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms.
    Njenga LW; Mbugua SN; Odhiambo RA; Onani MO
    Dalton Trans; 2023 May; 52(18):5823-5847. PubMed ID: 37021641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond platinums: gold complexes as anticancer agents.
    Nardon C; Boscutti G; Fregona D
    Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold (III) Derivatives in Colon Cancer Treatment.
    Gurba A; Taciak P; Sacharczuk M; Młynarczuk-Biały I; Bujalska-Zadrożny M; Fichna J
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with
    Hildebrandt J; Häfner N; Görls H; Barth MC; Dürst M; Runnebaum IB; Weigand W
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin.
    Spreckelmeyer S; Orvig C; Casini A
    Molecules; 2014 Sep; 19(10):15584-610. PubMed ID: 25268716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs.
    Todorov L; Kostova I
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-Responsive Therapeutic Metallodrugs.
    Wang X; Wang X; Jin S; Muhammad N; Guo Z
    Chem Rev; 2019 Jan; 119(2):1138-1192. PubMed ID: 30299085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supramolecular Delivery Systems for Non-Platinum Metal-Based Anticancer Drugs.
    Ringhieri P; Morelli G; Accardo A
    Crit Rev Ther Drug Carrier Syst; 2017; 34(2):149-183. PubMed ID: 28605318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
    Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent development of transition metal complexes with in vivo antitumor activity.
    Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
    J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.